Literature DB >> 12605220

Ready to partner.

Mark X Sliwkowski.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12605220     DOI： 10.1038/nsb0303-158

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN： 1072-8368


× No keyword cloud information.
  12 in total

Review 1.  Perspectives of HER2-targeting in gastric and esophageal cancer.

Authors:  James N Gerson; Sam Skariah; Crystal S Denlinger; Igor Astsaturov
Journal:  Expert Opin Investig Drugs       Date:  2017-05       Impact factor: 6.206

2.  Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.

Authors:  A Sett; B B Borthakur; U Bora
Journal:  Clin Transl Oncol       Date:  2017-02-21       Impact factor: 3.405

3.  Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysis.

Authors:  Chee M Ng; Bert L Lum; Veronica Gimenez; Steve Kelsey; David Allison
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

4.  Interleukin-6 is required for Neuregulin-1 induced HER2 signaling in lung epithelium.

Authors:  Rangnath Mishra; Daniel G Foster; James H Finigan; Jeffrey A Kern
Journal:  Biochem Biophys Res Commun       Date:  2019-04-16       Impact factor: 3.575

Review 5.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

6.  Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.

Authors:  Maolan Li; Zhou Zhang; Xiaoguang Li; Junyi Ye; Xiangsong Wu; Zhujun Tan; Chang Liu; Baiyong Shen; Xu-An Wang; Wenguang Wu; Daizhan Zhou; Di Zhang; Ting Wang; Bingya Liu; Kai Qu; Qichen Ding; Hao Weng; Qian Ding; Jiasheng Mu; Yijun Shu; Runfa Bao; Yang Cao; Peizhan Chen; Tianyu Liu; Lin Jiang; Yunping Hu; Ping Dong; Jun Gu; Wei Lu; Weibin Shi; Jianhua Lu; Wei Gong; Zhaohui Tang; Yong Zhang; Xuefeng Wang; Y Eugene Chin; Xiaoling Weng; Hong Zhang; Wei Tang; Yonglan Zheng; Lin He; Hui Wang; Yun Liu; Yingbin Liu
Journal:  Nat Genet       Date:  2014-07-06       Impact factor: 38.330

Review 7.  Targeting the function of the HER2 oncogene in human cancer therapeutics.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

Review 8.  Mimotope vaccination--from allergy to cancer.

Authors:  Regina Knittelfelder; Angelika B Riemer; Erika Jensen-Jarolim
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

9.  Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.

Authors:  Joseph Wahler; Nanjoo Suh
Journal:  Curr Pharmacol Rep       Date:  2015-04-19

10.  Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.

Authors:  Yalai Bai; Huan Cheng; Jennifer Bordeaux; Veronique Neumeister; Sudha Kumar; David L Rimm; David F Stern
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.